Acrux Limited has released a press release.
Capital Gains Tax exemptions remain in place for Acrux
Earlier from Acrux
- Acrux raises $1.6 million via Share Placement
- Australian company unlocks a new era for women's health globally with an innovative delivery system for Female testosterone in women with low libido
- Acrux strategy focuses on Female Testosterone for low libido
- Acrux receives $0.55m advance on FY26 R&D Tax Incentive